Seres Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
40.8 M |
Public Float |
14.32 M |
Seres Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.33 |
Market Cap |
$210.06 M |
Shares Outstanding |
69.91 M |
Public Float |
20.75 M |
Address |
200 Sidney Street Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.serestherapeutics.com |
Updated | 07/08/2019 |
Seres Therapeutics, Inc. is a microbiome therapeutics platform company, which engages in the development of biological drugs. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. |